Spots Global Cancer Trial Database for Surveillance Modified by Artificial Intelligence in Endoscopy (SMARTIE)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Surveillance Modified by Artificial Intelligence in Endoscopy (SMARTIE)
Official Title: Multicenter Evaluation Study of the CADe System ENDOMIND in Surveillance Endoscopy for Colorectal Cancer in German Outpatient Cohort
Study ID: NCT05006092
Interventions
Study Description
Brief Summary: Evaluation of an artificial intelligence system for polyp detection (CADe)
Detailed Description: We aim to evaluate the artificial intelligence system ENDOMIND that supports endoscopist in detection of polyps during surveillance endoscopy for colorectal cancer. 1070 patients out of 6 gastroenterologic practice are randomized 1:1 for conventional surveillance colonoscopy vs. surveillance with AI support. Primary endpoint is Adenoma detection rate.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Universitätsklinikum Würzburg, Würzburg, Bayern, Germany
Contact Details
Name: Alexander Hann
Affiliation: Wuerzburg University Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
